BR9711057A - M-todo para aumentar a efic cia de um composto antifÚngio usado para tratar uma infec-Æo fÚngica m-todo para tratar uma infec-Æo fÚngica composi-Æo farmaceutica e m-todo para controlar o crescimento de um organismo fungico em um substrato a ser inserido no corpo - Google Patents

M-todo para aumentar a efic cia de um composto antifÚngio usado para tratar uma infec-Æo fÚngica m-todo para tratar uma infec-Æo fÚngica composi-Æo farmaceutica e m-todo para controlar o crescimento de um organismo fungico em um substrato a ser inserido no corpo

Info

Publication number
BR9711057A
BR9711057A BR9711057A BR9711057A BR9711057A BR 9711057 A BR9711057 A BR 9711057A BR 9711057 A BR9711057 A BR 9711057A BR 9711057 A BR9711057 A BR 9711057A BR 9711057 A BR9711057 A BR 9711057A
Authority
BR
Brazil
Prior art keywords
treat
fungal infection
fungal
effectiveness
growth
Prior art date
Application number
BR9711057A
Other languages
English (en)
Inventor
Marilyn S Whittemore
Original Assignee
Buckman Labor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Buckman Labor Inc filed Critical Buckman Labor Inc
Publication of BR9711057A publication Critical patent/BR9711057A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N61/00—Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
BR9711057A 1996-08-09 1997-08-08 M-todo para aumentar a efic cia de um composto antifÚngio usado para tratar uma infec-Æo fÚngica m-todo para tratar uma infec-Æo fÚngica composi-Æo farmaceutica e m-todo para controlar o crescimento de um organismo fungico em um substrato a ser inserido no corpo BR9711057A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2364296P 1996-08-09 1996-08-09
PCT/US1997/013902 WO1998006265A2 (en) 1996-08-09 1997-08-08 Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound, especially n-dodecyl-morpholine

Publications (1)

Publication Number Publication Date
BR9711057A true BR9711057A (pt) 1999-08-17

Family

ID=21816367

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9711057A BR9711057A (pt) 1996-08-09 1997-08-08 M-todo para aumentar a efic cia de um composto antifÚngio usado para tratar uma infec-Æo fÚngica m-todo para tratar uma infec-Æo fÚngica composi-Æo farmaceutica e m-todo para controlar o crescimento de um organismo fungico em um substrato a ser inserido no corpo

Country Status (8)

Country Link
US (1) US5925616A (pt)
EP (1) EP0923375A2 (pt)
JP (1) JP2000516928A (pt)
AU (1) AU739591B2 (pt)
BR (1) BR9711057A (pt)
CA (1) CA2263077A1 (pt)
NZ (1) NZ334409A (pt)
WO (1) WO1998006265A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002098463A1 (fr) * 2001-06-05 2002-12-12 The New Industry Research Organization Compositions antifongiques
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US7521418B2 (en) * 2003-05-27 2009-04-21 Theravance, Inc. Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent
WO2005018743A1 (en) * 2003-07-22 2005-03-03 Theravance, Inc. Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent
CN101829319A (zh) 2003-12-08 2010-09-15 Cpex药品公司 用于胰岛素治疗的药用组合物及方法
CA2572223C (en) 2004-06-25 2014-08-12 The Johns Hopkins University Angiogenesis inhibitors
US20100055056A1 (en) * 2008-09-04 2010-03-04 Sato Pharmaceutical Co., Ltd. Agent for improving permeation of a drug into a nail and an external treating agent containing the same
WO2010062900A2 (en) * 2008-11-26 2010-06-03 Board Of Regents, The University Of Texas System A new family of pain producing substances and methods to produce novel analgesic drugs
US9029342B2 (en) 2012-09-17 2015-05-12 Board Of Regents Of The University Of Texas System Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof
CN114053417A (zh) * 2016-07-12 2022-02-18 马丁尼斯生物制药纳米技术公司 用于中枢神经系统递送和治疗隐球菌感染的脂质卷包封的抗真菌化合物
KR20180046730A (ko) * 2016-10-28 2018-05-09 (주)앰틱스바이오 알라닌 및 프롤린 아미노산의 기능적 유도체 화합물 및 이를 포함하는 약학적 조성물
US20220096512A1 (en) * 2019-01-31 2022-03-31 Sigma-Aldrich Co. Llc Water-based antifungal compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108991A (en) * 1975-06-19 1992-04-28 Whitby Research, Inc. Vehicle composition containing 1-substituted azacycloalkan-2-ones
JPS59501776A (ja) * 1982-09-13 1984-10-25 ハイドロマ　インコ−ポレイテツド 抗細菌性の医療材料及び器具
US5218113A (en) * 1986-01-31 1993-06-08 Whitby Research, Inc. N-substituted thiolactams
HU198825B (en) * 1987-03-09 1989-12-28 Chinoin Gyogyszer Es Vegyeszet Synergic fungicides
DE3935113A1 (de) * 1989-10-21 1991-04-25 Basf Ag Fungizide mischung
US5229397A (en) * 1989-10-21 1993-07-20 Basf Aktiengesellschaft Fungicidal mixture
US5250194A (en) * 1991-02-13 1993-10-05 Buckman Laboratories International, Inc. N-dodecyl heterocyclic compounds useful as industrial microbicides and preservatives
AU1579092A (en) * 1991-02-27 1992-10-06 Nova Pharmaceutical Corporation Anti-infective and anti-inflammatory releasing systems for medical devices
DE4343176A1 (de) * 1993-12-17 1995-06-22 Basf Ag Fungizide Mischung
US5587358A (en) * 1994-05-09 1996-12-24 Asahi Kasei Kogyo Kabushiki Kaisha Potentiators of antimicrobial activity

Also Published As

Publication number Publication date
CA2263077A1 (en) 1998-02-19
US5925616A (en) 1999-07-20
AU4055597A (en) 1998-03-06
AU739591B2 (en) 2001-10-18
WO1998006265A3 (en) 1998-03-19
EP0923375A2 (en) 1999-06-23
NZ334409A (en) 2000-06-23
JP2000516928A (ja) 2000-12-19
WO1998006265A2 (en) 1998-02-19

Similar Documents

Publication Publication Date Title
IT8522574A0 (it) Composizione farmaceutica eprocedimento per trattare il corpo umano con essa.
BR9500659A (pt) Composto composição farmacêutica e método de tratamento ou prevenção de uma condição causada por uma injeção bacteriana
BR9711057A (pt) M-todo para aumentar a efic cia de um composto antifÚngio usado para tratar uma infec-Æo fÚngica m-todo para tratar uma infec-Æo fÚngica composi-Æo farmaceutica e m-todo para controlar o crescimento de um organismo fungico em um substrato a ser inserido no corpo
EP0908186A3 (en) Method for treating pain
TR200402565T4 (tr) Hepatit delta virüsü enfeksiyonunun tedavi edilmesinde ß-L-2'-deoksi-nükleosidlerin kullanımı
HUT76258A (en) Compositions comprising dna damaging agents and p53, and methods for uses thereof
NO992097L (no) Polymerholdig preparat med kontrollert avgivelse av aktiv forbindelse
BR9608368A (pt) Método para aumentar a eficácia de um agente microbicida composição microbicida e método para controlar o crescimento de microorganismos
BR9504491A (pt) Composto composiçao farmacêutica métodos para a inibiçao do tip IV de fosfodiesterase e de tratar ou prevenir um estado precário de saude
AU2001262401A1 (en) Use of ellagic acid as anti-pollution cosmetic agent
WO1997003188A3 (de) Verwendung von mp52 oder mp121 zur behandlung und prävention von erkrankungen des nervensystems
GB9512542D0 (en) Titanium and zirconium complexes of carbolic acids as corrosion inhibitors
DK0840548T3 (da) Synergistisk, herbicid sammensætning samt fremgangsmåde til fremstilling deraf
PT1082016E (pt) Revestimento biologico com um efeito protector e curativo para o controlo do decaimento pos-colheita
DK0901790T3 (da) Anvendelse af moxonidin til behandling af neuropatisk smerte
AU4376396A (en) Use of andrographolide compounds to treat or prevent pathogenicity of diseases
WO2001010427A3 (en) Use of anti-muscarinic agents for treating skin disorders
NO992098L (no) Preparat med regulert avgivelse av aktiv forbindelse
BR9708864A (pt) Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamífero
BR9708525A (pt) Método de tratamento de insuficência cardíaca com antagonistas de endotelina
SE0100684D0 (sv) New subject-matter
AU623165B2 (en) Method of inhibiting the spread of disease and infection in structures
WO2001000197A3 (en) Methods of treating fungal infections with inhibitors of nad synthetase enzyme
AU1656997A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
ES2104223T3 (es) 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A,8A,9 E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1912 DE 28/08/2007.